Volume 21, Number 5, 265-268, DOI: 10.1023/A:1006057204609

Published in partnership with the

Logo

Society for Ophthalmo-Immuno Infectiology in Europe

Intravenous acyclovir treatment for extensive herpetic keratitis in a liver transplant patient

Tzafrir Oshry and Tova Lifshitz

View Related Documents

Abstract

Herpetic infection is a common complication among immune suppressed patients following heart, kidney and bone marrow transplantations,in leukemia patients, in AIDS patients, and during treatment with cytotoxic drugs. In the cases described in the literature, oral acyclovir was recommended as a treatment for the acute infection, as well as for prophylaxis. Intravenous acyclovir is not a routine treatment for herpetic keratitis, but is recommended for cases of insufficient clinical response to oral treatment, and defective absorption of acyclovir by the gastrointestinal tract. We present a patient who underwent 4 liver transplantations,was treated regularly with immunosuppressive drugs, and who developed extensive herpetic keratitits. The keratitis was resistant to both topical ointment and oral acyclovir treatment. Recovery was only achieved following the intravenous administration of acyclovir. We recommend intravenous acyclovir treatment at avery early stage for immune suppressed patients with extensive herpes simplex keratitis.

herpes - keratitis - acyclovir - immunosuppression

This revised version was published online in July 2006 with corrections to the Cover Date.

Fulltext Preview

Image of the first page of the fulltext document